Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2023

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Segment data were as follows:

	For the Nine Months Ended September 30,				For the Three Months Ended September 30,
(in millions)	2023		2022		2023		2022
Net revenues:
Smokeable products	$	16,482	$	17,020	$	5,572	$	5,882
Oral tobacco products	1,993		1,948		685		670
All other	33		17		24		(2)
Net revenues	$	18,508	$	18,985	$	6,281	$	6,550
Earnings before income taxes:
OCI:
Smokeable products	$	8,092	$	8,112	$	2,743	$	2,791
Oral tobacco products	1,314		1,262		455		425
All other	(17)		(27)		(4)		(7)
Amortization of intangibles	(87)		(54)		(42)		(19)
General corporate expenses	(551)		(192)		(63)		(78)
Operating income	8,751		9,101		3,089		3,112
Interest and other debt expense, net	758		832		272		271
Net periodic benefit income, excluding service cost	(95)		(137)		(33)		(44)
(Income) losses from investments in equity securities	(105)		3,707		(58)		2,478
Loss on Cronos-related financial instruments	—		14		—		—
Earnings before income taxes	$	8,193	$	4,685	$	2,908	$	407

Schedule of Tobacco and Health and Certain Other Litigation Items

We recorded pre-tax charges related to tobacco and health and certain other litigation items as follows:

	For the Nine Months Ended September 30,				For the Three Months Ended September 30,
(in millions)	2023		2022		2023		2022
Smokeable products segment	$	65	$	71	$	13	$	21
General corporate expenses	348		27		10		20
Interest and other debt expense, net	11		3		—		2
Total	$	424	$	101	$	23	$	43